| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.1M | -19.6% |
| Cost of Revenue | $9.7M | -17.9% |
| Gross Profit | $18.5M | -20.5% |
| R&D Expense | $10.6M | +3.5% |
| SG&A Expense | $14.4M | +2.8% |
| Operating Income | -$18.8M | -45.7% |
| Net Income | -$18.3M | -70.7% |
| EPS (Basic) | -$0.26 | -62.5% |
| EPS (Diluted) | -$0.26 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -77.8% |
| Short-term Investments | $19.8M | — |
| Accounts Receivable | $5.1M | -5.8% |
| Inventory | $7.9M | +77.7% |
| Current Assets | $43.2M | -15.8% |
| Total Assets | $53.4M | -12.4% |
| Current Liabilities | $14.3M | +7.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.4M | -185.7% |
| Investing Cash Flow | -$22.1M | -1482.0% |
| Financing Cash Flow | $220K | -59.8% |
| -62.5% |
| Total Liabilities |
| $21.5M |
| -0.4% |
| Stockholders' Equity | $26.3M | -22.1% |